Can Unconventional Immunomodulatory Agents Help Alleviate COVID-19 Symptoms and Severity?

Severe acute respiratory syndrome coronavirus 2 (SARS coronavirus 2, or SARS-CoV-2) is the cause of the respiratory infection known as COVID-19. From an immunopathological standpoint, coronaviruses such as SARS-CoV-2 induce increased levels of a variety of T-helper 1 (Th1) and inflammatory cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamber, Stephen W., Krakowka, Steven, Osborn, Jeffrey, Saberski, Lloyd, Rhodes, Ryan G., Dahlberg, Albert E., Pond-Tor, Sunthorn, Fitzgerald, Kara, Wright, Neal, Beseme, Sarah, McMichael, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Opinion/Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227768/
https://www.ncbi.nlm.nih.gov/pubmed/32404512
http://dx.doi.org/10.1128/mSphere.00288-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227768/
https://www.ncbi.nlm.nih.gov/pubmed/32404512
http://dx.doi.org/10.1128/mSphere.00288-20

Ejemplares similares